List of Substances Under PSUR WS Scheme and Other Substances

List of Substances Under PSUR WS Scheme and Other Substances

ABCDEFGHIJKL List of substances under PSUR Work Sharing scheme and other substances contained in Nationally Authorised Products with DLP synchronised Status July 2013 In brown font: changes made since last publication on 30th June 2013 1 Are PSURs required for Substances under PSUR Submission of Innovator brand products referred Work Sharing scheme PSURs by name (for fixed DLP (year Allocated PRMS / Note on PSUR to in Articles or Others (contained in Active substance name (INN) EU HBD Firm's Name Comments Next DLP (DLP + 90 combination and month) Procedure number cycle 10(1), 10a, 14 and Nationally Authorised days by products only) 16a of Directive Products including default) 2001/83/EC as MRP/DCP) 2 amended? sulbactam No, except if required nationally 19871116 201311 Pfizer AT/H/PSUR/0004/003 201402 Work Sharing by a competent 3 authority idarubicin No, except if required nationally 19891129 201311 Pfizer AT/H/PSUR/0005/003 201402 Work Sharing by a competent 4 authority dexibuprofen No, except if required nationally 20000725 31/08/2014 Gebro Pharma AT/H/PSUR/0009/003 29/11/2014 Work Sharing by a competent 5 authority nicorandil No, except if required nationally 19900209 201302 Merck AT/H/PSUR/0023/002 201305 Work Sharing by a competent 6 authority azelastine Request from MEDA Pharma GmbH & Co.KG to amend the DLP to 31/12/2014. Request agreed by the P- No, except if RMS AT. The substance has required nationally 20/11/1990 201309 Meda been moved to the EURD AT/H/PSUR/0038/001 201312 Work Sharing by a competent list as detailed in the cover note "Assessment of authority Periodic Safety Update Reports for National 7 Authorised" Product biperiden No, except if required nationally 19550816 201308 Abbott AT/H/PSUR/0039/001 201311 Work Sharing by a competent 8 authority calcium carbonate, No, except if colecalciferol required nationally 01/01/1960 201310 Nycomed AT/H/PSUR/0040/001 201401 Work Sharing by a competent 9 authority The PSURs submitted for human coagulation factor IX products containing human coagulation factor IX and authorised nationally will be assessed under a single assessment procedure with the centrally No, except if authorised product required nationally 12/07/1985 201307 Baxter AT/H/PSUR/0041/001 201310 Work Sharing Nonafact. For more by a competent details, please refer to authority the EURD list: http://www.emea.europa .eu/ema/index.jsp?curl=p ages/regulation/documen t_listing/document_listing _000361.jsp&mid=WC0b 10 01ac058066f910 human coagulation factor VII No, except if required nationally 01/11/1975 201310 Baxter AT/H/PSUR/0042/001 201401 Work Sharing by a competent 11 authority PSUR Work Sharing list - July 2013 ABCDEFGHIJKL Are PSURs required for Substances under PSUR Submission of Innovator brand products referred Work Sharing scheme PSURs by name (for fixed DLP (year Allocated PRMS / Note on PSUR to in Articles or Others (contained in Active substance name (INN) EU HBD Firm's Name Comments Next DLP (DLP + 90 combination and month) Procedure number cycle 10(1), 10a, 14 and Nationally Authorised days by products only) 16a of Directive Products including default) 2001/83/EC as MRP/DCP) 2 amended? human coagulation factor No, except if VIII (inhibitor bypassing required nationally 04/02/1977 31/01/2014 AT/H/PSUR/0043/001 01/05/2014 Work Sharing fraction) by a competent 12 authority domperidone / domperidone The previous entry maleate, cinnarizine "domperidone maleate, cinnarizine " with procedure number 19780300 201301 J&J BE/H/PSUR/0005/003 yearly PSURs 201401 201304 Yes Work Sharing BE/H/PSUR/0020/00X has been merged with the entry "domperidone " 13 standalone 14 vecuronium bromide 19901101 201311 Organon CZ/H/PSUR/0002/003 201402 Yes Work Sharing 15 levobunolol 19890608 01/06/2014 Allergan CZ/H/PSUR/0006/003 30/08/2014 Yes Work Sharing tirofiban No, except if required nationally 20030514 201305 IROKO DE/H/PSUR/0001/002 201308 Work Sharing by a competent 16 authority 17 ezetimibe + simvastatin Inegy 20040402 201403 MSD DE/H/PSUR/0020/002 201406 Yes Work Sharing 18 mefloquine 19850517 30/04/2013 Roche DE/H/PSUR/0022/003 19/02/2014 29/07/2013 Yes Work Sharing moxifloxacin (systemic use) 19990531 201305 Bayer Schering DE/H/PSUR/0023/004 2 yearly PSURs 201308 Yes Work Sharing 19 dienogest + ethinylestradiol No, except if Omitted from the required nationally Valette 19950214 201303 Bayer Schering publication on DE/H/PSUR/0030/002 201306 Work Sharing by a competent 27/03/2013 20 authority gabapentin No, except if Substance omitted in required nationally 19930205 201302 Pfizer DE/H/PSUR/0035/002 201305 Work Sharing publication of March 2013 by a competent 21 authority modafinil No, except if required nationally 19940901 201308 Cephalon DE/H/PSUR/0044/003 yearly PSURs 201311 Work Sharing by a competent 22 authority ciprofloxacin hydrochloride, No, except if dexamethasone acetate (ear Alcon Pharma DE volunteered to act as required nationally 31/05/2012 30/04/2013 DE/H/PSUR/0047/001 29/07/2013 Work Sharing drops, suspension) GmbH P-RMS by a competent 23 authority atorvastatin (paediatric No, except if indication) DE accepts to act as P- required nationally 07/11/1996 31/10/2013 Pfizer DE/H/PSUR/0048/001 yearly PSURs 29/01/2014 Other RMS by a competent 24 authority dorzolamide + timolol No, except if required nationally Cosopt 19980306 201302 MSD DK/H/PSUR/0001/003 201305 Work Sharing by a competent 25 authority 26 oxcarbazepine 19990810 201308 Novartis DK/H/PSUR/0002/003 201311 Yes Work Sharing 27 bicalutamide 19950228 201402 AstraZeneca DK/H/PSUR/0006/003 201405 Yes Work Sharing fluconazole No, except if required nationally 19880303 201403 Pfizer DK/H/PSUR/0008/003 201406 Work Sharing by a competent 28 authority 29 pimecrolimus 20011214 201303 Novartis DK/H/PSUR/0009/006 yearly PSURs 201403 201306 Yes Work Sharing technetium (99mTc) bicisate No, except if required nationally 19831008 201310 LANTHEUS MI DK/H/PSUR/0012/003 201401 Work Sharing by a competent 30 authority 31 misoprostol 19840628 30/06/2014 Pfizer DK/H/PSUR/0014/003 28/09/2014 Yes Work Sharing 32 epirubicin 19820628 30/06/2014 Pfizer DK/H/PSUR/0016/003 28/09/2014 Yes Work Sharing 33 acitretin 19871201 201310 Actavis DK/H/PSUR/0024/003 yearly PSURs 201401 Yes Work Sharing PSUR Work Sharing list - July 2013 ABCDEFGHIJKL Are PSURs required for Substances under PSUR Submission of Innovator brand products referred Work Sharing scheme PSURs by name (for fixed DLP (year Allocated PRMS / Note on PSUR to in Articles or Others (contained in Active substance name (INN) EU HBD Firm's Name Comments Next DLP (DLP + 90 combination and month) Procedure number cycle 10(1), 10a, 14 and Nationally Authorised days by products only) 16a of Directive Products including default) 2001/83/EC as MRP/DCP) 2 amended? etoposide No, except if required nationally 19760217 201302 BMS DK/H/PSUR/0029/002 201305 Work Sharing by a competent 34 authority 35 gadoteridol 19921029 201302 Bracco DK/H/PSUR/0030/002 201305 Yes Work Sharing budesonide No, except if AstraZeneca / required nationally 19920430 201304 DK/H/PSUR/0041/002 201307 Work Sharing Dr. Falk Pharma by a competent 36 authority 37 ebastine 19960101 201305 Almirall DK/H/PSUR/0043/002 201308 Yes Work Sharing ferumoxsil (siloxane coated No, except if superparamagnetic required nationally 19930122 201305 Guerbet DK/H/PSUR/0044/002 201308 Work Sharing ironoxide) by a competent 38 authority technetium(99mTc) macrosalb No, except if required nationally 19900302 201302 Ge Healthcare DK/H/PSUR/0048/002 201305 Work Sharing by a competent 39 authority ethinylestradiol + Nordette, Stediril, levonorgestrel Follimin, Trinordiol, Nordiol, Ovran 21, Neogestrenol, Stediril-d, Lorette, 19650422 / No, except if Lowette, Alesse, 19760427 / Pfizer / Bayer required nationally 201304 DK/H/PSUR/0054/002 201307 Work Sharing Loette, Gravistat 19650422 / Schering by a competent 125, Microgynon, 19970327 authority Monostep, Minisiston, Triquilar, Miranova, Neogynon 40 sodium iodide [123I] No, except if required nationally 19950131 201303 Ge Healthcare DK/H/PSUR/0056/001 201306 Work Sharing by a competent 41 authority mepivacaine No, except if required nationally 19560401 201303 AstraZeneca DK/H/PSUR/0057/001 201306 Work Sharing by a competent 42 authority mepivacaine + adrenaline No, except if Carbocaine- required nationally 19560401 201303 Astrazeneca DK/H/PSUR/0058/001 201306 Work Sharing Adrenaline by a competent 43 authority ethinylestradiol + gestodene Combination transferred from FR to DK Minesse, 19990614 / No, except if Harmonet, Tri- 19950317 / Pfizer / Bayer Awaiting outcome of the required nationally minulet, Minulet, 201403 DK/H/PSUR/0060/001 201406 Work Sharing 19980127 / Schering on-going EU referral by a competent Mirelle, Meliane, 19860709 procedure to know authority Femovan, Milvane whether the DLP needs to 44 be modified. nortriptyline No, except if required nationally 19630331 201303 Lundbeck EE/H/PSUR/0010/002 201306 Work Sharing by a competent 45 authority cinitapride No, except if required nationally 19930311 201306 Almirall ES/H/PSUR/0001/002 201309 Work Sharing by a competent 46 authority lovastatin No, except if required nationally 19870721 201307 MSD ES/H/PSUR/0002/002 201310 Work Sharing by a competent 47 authority PSUR Work Sharing list - July 2013 ABCDEFGHIJKL Are PSURs required for Substances under PSUR Submission of Innovator brand products referred Work Sharing scheme PSURs by name (for fixed DLP (year Allocated PRMS / Note on PSUR to in Articles or Others (contained in Active substance name (INN) EU HBD Firm's Name

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    23 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us